China Biologic Products, Inc. (CBPO) Reports Q2 EPS of $0.82
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- Wall Street ends lower, off record highs, as Treasury yields climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
Tweet
Share
E-mailGet Alerts CBPO Hot Sheet
Join SI Premium – FREE
China Biologic Products, Inc. (NASDAQ: CBPO) reported Q2 EPS of $0.82, versus $0.62 reported last year. Revenue for the quarter came in at $60.1 million, versus $53.6 million reported last year.
For earnings history and earnings-related data on China Biologic Products, Inc. (CBPO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Some Said Inflation Risks Had Become More Skewed To Upside - FOMC Minutes
- Hess Midstream stock drops on Chevron restructuring and lower 2027 outlook
- FDA approves Pfizer's Tukysa as front-line maintenance for HER2+ breast cancer
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
